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Latrotoxin Receptor Signaling
Engages the UNC-13-Dependent
Vesicle-Priming Pathway in C. elegans
tent with an -latrotoxin (LTX)-like action [6], and func-
tional studies indicate that the predominant target site
of emodepside is presynaptic [7]. To directly test for a
LTX-like action of emodepside on C. elegans neurons,
we dissected pharyngeal muscle and the embedded
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min. As a functional correlate of this image analysis, we
observed that emodepside (0.125 nM to 1M) paralyzed
the pharynx of intact adult animals. Emodepside alsoSummary
had marked effects on tissues other than the pharynx.
It immobilized mature adults and inhibited egg laying.-latrotoxin (LTX), a 120 kDa protein in black widow
Interestingly, at this range of concentrations, emodep-spider venom, triggers massive neurotransmitter exo-
side had little if any effect on larval animals.cytosis. Previous studies have highlighted a role for
The potent effect of emodepside on C. elegans phar-both intrinsic pore-forming activity and receptor bind-
ynx enabled us to take advantage of established tech-ing in the action of this toxin [1]. Intriguingly, activation
niques for electrophysiological analysis (electropha-of a presynaptic G protein-coupled receptor, latrophi-
ryngeogram, EPG) of this muscle in order to quantifylin, may trigger release independent of pore-formation
its action [9]. Emodepside inhibited basal pharyngeal[2]. Here we have utilized a previously identified ligand
pumping rate (IC50 2.2 nM; data not shown) and theof nematode latrophilin, emodepside [3], to define a
response of the pharynx to two stimulatory neurotrans-latrophilin-dependent pathway for neurotransmitter
mitters [10], either 5-HT (IC50 4.1 nM; Figures 2A and 2B)release in C. elegans. In the pharyngeal nervous sys-
or AF1 (Figure S4). Therefore, emodepside inhibits bothtem of this animal, emodepside (100 nM) stimulates
the tonically-active pharynx, and pharyngeal pumpingexocytosis and elicits pharyngeal paralysis. The phar-
stimulated by pharmacological activation of the entericynxes of animals with latrophilin (lat-1) gene knock-
neuronal circuit. The cyclic structure of emodepside pre-outs are resistant to emodepside, indicating that emo-
sents the possibility that its action may derive from adepside exerts its high-affinity paralytic effect through
nonspecific, receptor-independent pore-forming capa-LAT-1. The expression pattern of lat-1 supports the
bility. However, PF1022-001, a structural isomer of thehypothesis that emodepside exerts its effect on the
lead compound for emodepside that has the same pore-pharynx primarily via neuronal latrophilin. We build
forming capability [11], has no inhibitory action on theon these observations to show that pharynxes from
pharynx at concentrations up to 10 M (n  6; data notanimals with either reduction or loss of function mu-
shown). As a caveat to this, it should be noted that thetations in Gq, phospholipaseC-, and UNC-13 are
pore-forming capability of LTX in biological membranesresistant to emodepside. The latter is a key priming
requires tethering of LTX to the membrane by bindingmolecule essential for synaptic vesicle-mediated re-
to specific receptors [12]. Therefore, we cannot discountlease of neurotransmitter [4, 5]. We conclude that the
the possibility that the lack of effect of PF1022-001 maysmall molecule ligand emodepside triggers latrophilin-
reflect an inability of the isomer to bind to a membranemediated exocytosis via a pathway that engages UNC-
receptor prior to pore formation. However, previous13-dependent vesicle priming.
studies have shown that a linear form of cyclooctadepsi-
peptide has biological activity and inhibits muscle in the
Results and Discussion large parasitic nematode, Ascaris suum [11], providing
further weight to the contention that the paralytic action
Emodepside belongs to a new class of drugs, the of emodepside does not derive from pore-forming capa-
cyclooctadepsipeptides [6] (Figure S1 in the Supple- bility.
mental Data available with this article online). These The studies with FM4-64 indicate emodepside may
compounds bind to nematode latrophilin-like receptors inhibit the pharynx by stimulation of neurotransmitter
[3]. Emodepside causes paralysis in nematodes, consis- release. To test for this, we made intracellular recordings
from pharyngeal muscle and monitored effects on mem-
brane potential. Emodepside (100 nM) elicited a slow*Correspondence: lmhd@soton.ac.uk
Latrophilin Action through Gq, PLC- and UNC-13
1375
Figure 1. The Effect of Emodepside on Exo-
cytosis from C. elegans Pharyngeal Neurons
Pharynxes, with their embedded enteric neu-
rons, were dissected from a strain with pan-
neuronal GFP expression (NW1229); and
loaded with FM4-64 [37]. The pharynxes were
incubated with 5 M FM4-64 in the presence
of high potassium Dent’s (mM: 144 NaCl, 10
MgCl2, 1 CaCl2 25 KCl, and 5 Hepes, [pH 7.4])
for 5 min followed by a wash in 6 mM KCl
Dent’s.
(A) Diagram showing the position of the isth-
mus within the C. elegans pharynx (dotted
rectangle) where FM4-64 labeling was im-
aged. Images represent Z-series of 50 slices,
total depth 23.9 m.
(B) Colocalization of FM4-64 staining with
GFP labeled neurons (left), FM4-64 staining
(middle), and merged image (right). Yellow in-
dicates colocalization of FM4-64 and GFP.
(C) FM4-64 staining following loading in high
potassium (which marks regions with high
vesicle recycling prior to drug addition, left).
FM4-64 staining following 10 min addition
0.1% ethanol vehicle (middle). FM4-64 stain-
ing following 10 min 100 nM emodepside ad-
dition (right).
(D) The same preparation as in (C), showing
the overlay of red and green fluorescence.
This confirms that, despite some movement
of the pharynx during the experiment, there
is loss of red FM4-64 fluorescence from the
GFP labeled neuronal regions. Prolonged ap-
plication of emodepside ( 1 hr) did not lead
to a disruption in the integrity of the dissected pharynx or associated enteric neurons. Furthermore, in another series of experiments we noted
that primary cultures of GFP expressing C. elegans neurons maintained their integrity in the continued presence of emodepside (100 nM for
24 hr; data not shown). These observations support the conclusion that emodepside does not cause physical disruption of biological
membranes.
depolarization (5.8  2.6 mV; n  4) and inhibited potent effect of emodepside on C. elegans pharynx in-
volves latrophilin. To achieve this, we tested the effectpharyngeal action potential generation (Figure 2C). Glu-
tamate depolarizes the pharynx [13]; however, a putative of emodepside on a putative null gene deletion mutant,
lat-1(ok379), and on animals treated with double-null allele for the glutamate receptor, avr-15(ad1051)
[14], was not resistant to emodepside (n  10; data stranded RNA (dsRNA) for lat-1 to induce RNA interfer-
ence (RNAi). Interestingly, both the lat-1 knockout andnot shown). Therefore, it is unlikely that the action of
emodepside requires glutamate release alone. Perhaps lat-1 RNAi animals had a prolonged pharyngeal pump
duration compared to wild-type. For lat-1(ok379), thisthis is not surprising, because the pharyngeal nervous
system expresses a wide range of neurotransmitters was 220  19 ms (n  11), and for lat-1 RNAi, this was
225  23 ms (n  21) compared with a wild-type dura-that have effects on the pharyngeal muscle [10], any or
all of which could be released by an LTX-like action of tion of 162  16 ms [n  22; p  0.05 with respect to
lat-1(ok379); Figure 3A] and a duration of 180  13 msemodepside. We conclude that the effect of emodep-
side on pharyngeal membrane potential is likely to be (n 17) in the RNAi control (zero IPTG control; p  0.05
with respect to lat-1 RNAi). Extended pharyngeal pumpthe net result of release of multiple neurotransmitters.
Previous studies have shown that emodepside inter- duration is also observed in C. elegans mutants with
defective neurotransmission [16], although the effectacts with nematode latrophilin [3]. There are two candi-
date latrophilins in C. elegans through which emodep- observed in the lat-1 knockouts was not as marked.
These observations are consistent with the idea thatside may exert its effect, lat-1 (B0457.1) and lat-2
(B0286.2). Both lat-1 and lat-2 encode seven transmem- latrophilin has a physiological role in facilitating neuro-
transmitter release. Support for this also comes from abrane domain, Family 2, G protein-coupled receptors
with characteristics of latrophilins, including large ex- study in Drosophila showing that mutations in the G
protein-coupled receptor Methuselah (Mth), related totracellular and intracellular domains, a lectin-like se-
quence, a G protein proteolysis site domain (GPS), and latrophilin, results in a 50% decrease in evoked transmit-
ter release [17]. We also observed that lat-1(ok379) werea short cysteine-rich sequence [15] (Figure S2). LAT-1
has 22, 23, and 21% amino acid identities to rat, bovine, constipated, similar to an earlier report that RNAi for
lat-1 has this effect [18]. Importantly, these observationsand human latrophilin, respectively. LAT-1 and LAT-2
have 21% amino acid identity with each other. are indicative of physiological regulation of latrophilin
by an endogenous ligand.We performed experiments to determine whether the
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The pharynxes of lat-1(ok379) animals were resistant
to emodepside and continued to pump at concentra-
tions up to 100 nM emodepside (Table 1; Figure 3B).
This is corroborated by a similar observation for lat-1
RNAi (Table 1; Figure 3B). In contrast, emodepside was
still effective at inhibiting locomotion in the lat-1 knock-
out, with a potency indistinguishable from wild-type
(data not shown). This suggests that some other recep-
tor, perhaps lat-2, may be involved in mediating the
inhibitory action of emodepside on locomotion. In sup-
port of this, dsRNA targeted at lat-2 and a lat-2 gene
deletion mutant were both resistant to the effects of
emodepside on locomotion (data not shown).
Overall, the data support the conclusion that in C. ele-
gans pharynx, LAT-1 plays a pivotal role in the high-
affinity effect of emodepside. We found support for this
when examining the expression pattern of lat-1, by using
a lat-1::DsRed2 reporter construct. In larval stages, ex-
pression was most evident in the pharyngeal muscle,
consistent with earlier reports that used immunostaining
[6] (Figures 3C and 3D). There may also have been neu-
ronal expression in the larva, but this was hard to discern
in the pharynx region. However, in adults, lat-1 expres-
sion appeared to be lost from the muscle but was ex-
pressed in anterior neurons, both extra-pharyngeal and
pharyngeal, including one neuron in the terminal bulb
and neurons of the corpus, with projections into the
isthmus (Figures 3E and 3F). Notably, in the pharynx of
adult animals, which are most susceptible to emodep-
side, lat-1 is expressed in neurons rather than muscle.
These observations, derived from using pharyngeal
activity in C. elegans to determine the effect of emodep-
side, are consistent with the idea that it acts via a neu-
ronal latrophilin-signaling pathway. We gained further
insight into this pathway by screening for emodepside
resistance in several strains with mutations in genes
encoding candidate effector molecules. As latrophilin
copurifies with Gq and Go in mammalian cells [19],
Figure 2. The Effect of Emodepside on Pharyngeal Pumping we first tested emodepside in animals with mutations
Extracellular recordings of the pharyngeal muscle (EPG) were made in genes encoding these G proteins. A C. elegans mu-
as described in [9]. Individual worms were placed in a Petri dish tant, egl-30(ad806), which has a reduction-of-function
containing modified Dent’s saline (mM: 144 NaCl, 10 MgCl2, 1 CaCl2 mutation in the Gq protein [20], was emodepside resis-6 KCl, and 5 Hepes [pH 7.4]). A razor blade was used to cut the
tant (Table 1; Figure 4A), whereas a gain-of-functionworm just posterior to the pharynx, which caused the cuticle to
retract, exposing the isthmus and terminal bulb. This semi-intact mutant, egl-30(tg26) [21], was hypersensitive (Table 1;
worm preparation consisted of the pharynx, the nerve ring, and the Figure 4B). A Go reduction-of-function mutant [22],
enteric nervous system. goa-1(n1134), also showed hypersensitivity to emodep-
(A) Each vertical line represents the electrical activity associated side (Table 1; Figure 4B). In this context, it is interesting
with a single muscle pump; therefore, this provides a readout of the
to note that at the body wall neuromuscular junction inactivity of the muscle. The protocol involved applying 5-HT for 2
C. elegans, Go acts antagonistically to Gq [23, 24] withmin, to stimulate pumping, followed by a 10 min application of either
vehicle control (0.1% ethanol) or emodepside, and lastly, a second the latter facilitating neurotransmitter release [25, 26].
application of 5-HT for 2 min. The top trace shows a typical result Gq couples to the signaling molecule PLC-, which
from a control experiment in which the pharynx continues to pump is a key modulator of pathways that regulate vesicular-
throughout the entire time-course of the experiment. The bottom mediated release in C. elegans [26, 23]. To further track
trace shows the effect of 100 nM emodepside on pharyngeal pump-
the mechanism of action of emodepside, we utilized twoing. Note the disappearance of the pumps during the period of
C. elegans mutants, egl-8(md1971) and egl-8(n488), thatemodepside application and the failure of the muscle to respond
to the second application of 5-HT. encode PLC- [23]. These two alleles have disruptions
(B) Concentration-response curve for the effect of varying concen-
trations of emodepside on pharyngeal pumping rates in wild-type
C. elegans. “% control response” is the rate of pumping during the
ing was stimulated by the addition of 5-HT (500 nM), and the barsecond application of 5-HT (i.e., following emodepside application) as
a percentage of pumping rate elicited by the first application of 5-HT. indicates the duration of application of emodepside. Subsequent
application of 5-HT failed to elicit pumping (not shown). Note the(C) The effect of emodepside on the membrane potential was deter-
mined by making intracellular recordings from the terminal bulb, as small depolarizing shift from baseline membrane potential (indicated
by dotted line) upon application of emodepside.described in [13]. The trace shows an example. Pharyngeal pump-
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Figure 3. Latrophilin Signaling in the Pharynx
(A) lat-1(ok379) has a pharyngeal phenotype.
The traces show an electropharyngeogram
(EPG) [9] recorded from a wild-type and lat-
1(ok379) animal. Each recording represents
a single muscle pump, with the first upward
deflection corresponding to contraction and
the last downward deflection corresponding
to relaxation. The small potentials that appear
during the pump have been associated with
neuronal activity in the pharyngeal neuron
M3 [38].
(B) The role of LAT-1 in the inhibitory effect
of emodepside on the pharynx. Assays for
pharyngeal activity were performed as for
Figure 2A. The lat-1 control group for RNAi
was rrf-3(pk1426) [36] fed on bacteria trans-
formed with vectors for dsRNA but in the ab-
sence of IPTG so that the expression of dsRNA
was not induced. The graphs show concentra-
tion-response curves for the effect of emo-
depside on pharyngeal pumping in wild-type
with an IC50 of 4.1 nM (95% confidence limits
1.2 to 14.7 nM); lat-1(ok379) with an IC50 of
53 nM (95% confidence limits 26 to 109 nM);
rrf-3(pk1426) (dsRNA control) with an IC50 of
2.9 nM (95% confidence limits 0.3 to 10 nM);
and lat-1 RNAi with an IC50 of 70 nM (95% confidence limits 22 to 219 nM). Each point is the mean  S.E.M. of “n” determinations. *p  0.05 and
**p  0.01 with respect to control.
(C) The expression pattern of lat-1 was determined using a lat-1::DsRed2 reporter construct for expression of DsRed2 fused to the N-terminal
domain (51 amino acids) of LAT-1. Expression was only observed in the anterior region of the animal. (C) is a fluorescence image from the anterior
region of L3 stage larval animals.
(D) A fluorescence image from L3 superimposed on a bright field background. Note the distinctive labeling in the pharyngeal muscle (m).
(E) and (F) show images from the anterior of adult animals. (F) is a dissected pharynx showing a neuronal pattern of expression. One neuron
is marked “n” as an example. Confocal images were obtained on a Zeiss Axioskop 2 LSM 510 Meta laser scanning microscope consisting
of a Z-series of 24 sections, total depth 22.7 m.
in the catalytic Y domain of the enzyme. The pharynxes PLC- hydrolyses phosphatidylinositolbisphosphate
to generate inositol 1,4,5-trisphosphate (IP3) and diacyl-of these animals have a significantly reduced sensitivity
to emodepside (Table 1; Figure 4C). This supports a glycerol (DAG). Either or both IP3 and DAG may be
involved in the downstream signaling from PLC-. Insignaling pathway for emodepside through Gq and
PLC-. The relative reduction in sensitivity to emodep- mammals, IP3 is implicated in LTX receptor-mediated
activation of neurotransmitter release [27]. However, inside was similar for the lat-1 knockout, the Gq reduc-
tion of function mutant, and the PLC- mutant (Table C. elegans, IP3 receptors have a very limited expres-
sion pattern in the pharyngeal nervous system [28], sug-1), consistent with the hypothesis that they are in the
same signaling pathway for emodepside, which is nega- gesting a subsidiary role in neuronal signaling. Alterna-
tively, there is extensive evidence from the stimulatorytively regulated by Go (Figure S3).
Table 1. A Summary of the Effect of Emodepside on the Pharyngeal Pumping Frequency of Wild-Type and Mutant C. elegans
% Inhibition with 10 nM
Strain Emodepside IC50 nM emodepside
egl-30(tg26) 0.2 92  3 (5)*
goa-1(n1134) 0.4 85  5 (5)*
rrf-3(pk1426) 2.9 75  7 (5)
wild-type 4.1 60  8 (5)
egl-8(n488) 59 18  15 (9)*
egl-8(md1971) 79 4  4 (6)***
snb-1(md247) 123 1  8 (5)*
lat-1 RNAi 70 11  23 (5)**
lat-1(ok379) 53 8  8 (5)**
egl-30(ad806) 78 0  9 (5)**
unc-13(e1091) 203 12  27 (5)*
unc-13(s69) 360 20  20 (5)*
The mutants tested are listed in the left-hand column. The assay used is the same as that described in the legend for Figure 2A. Emodepside
was tested at five concentrations and each concentration was tested between 2 and 22 times (see Figure 4). These data were pooled to
construct inhibition curves, fitted to the modified logistic equation (GraphPad Prism, San Diego) from which IC50 values (the concentration of
emodepside that caused a 50% reduction in pharyngeal pumping frequency) were estimated. The right-hand column gives the % inhibition
observed at 10 nM emodepside ( S.E.M.; n; *p  0.05, **p  0.01; ***p  0.001 with respect to wild-type or rrf-3(pk1426), as appropriate).
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Figure 4. The Role of G Proteins, Phospholi-
paseC-, and Synaptic Proteins in the Action
of Emodepside
(A) Concentration-response curves showing
the effect of emodepside on pharyngeal
pumping in an egl-30 reduction of function
mutant (ad806; IC50 78 nM, 95% confidence
limits 7.4 to 829 nM).
(B) Concentration-response curves showing
the hypersensitivity of the gain of function
mutant egl-30 (tg26; IC50 0.2 nM, 95% confi-
dence limits 0.05 to 0.9 nM; control IC50  4.1
nM, 95% confidence limits 1.2 to 14.7 nM)
and goa-1 (reduction of function n1134; IC50
0.4 nM, 95% confidence limits 0.1 to 1.4 nM;
control IC50  4.1 nM 95% confidence limits
1.2 to 14.7 nM) to emodepside.
(C) Concentration-response curves showing
the effect of emodepside on pharyngeal
pumping on egl-8 (md1971 reduction of func-
tion; IC50  79 nM, 95% confidence limits 32
to 192 nM; control IC50  4.1 nM 95% confi-
dence limits 1.2 to 14.7 nM). Dashed line
shows results for the effect of emodepside
on pharyngeal pumping on egl-8 (n488; re-
duction of function; IC50  59 nM, 95% confi-
dence limits 23 to 147 nM).
(D) Concentration-response curves showing the effect of emodepside on pharyngeal pumping of unc-13 (reduction of function; e1091; IC50 
203 nM, 95% confidence limits 28 nM to 1454 nM; control IC50  4 nM, 95% confidence limits 1.7 to 9.8 nM), unc-13 (s69, severe reduction
of function; IC50  360 nM, 95% confidence limits 68 to 1905 nM) and snb-1 (reduction of function; md247; IC50  123 nM, 95% confidence
limits 33 to 460 nM). Each point is the mean  S.E.M. of (n) determinations. *p  0.05, **p  0.01, and ***p  0.001, with respect to wild-type.
action of -phorbol esters on synaptic transmission that In conclusion, our results reinforce the functional sig-
nificance of latrophilin in the regulation of neurotransmit-implicates DAG in the regulation of neurotransmitter re-
lease [26, 29]. A major presynaptic DAG receptor is ter release [17]. Furthermore, we have linked latrophilin
to a signaling pathway involving Gq and PLC-, which(m)UNC-13 [30]. (m)UNC-13 is an active-zone-specific
plasma membrane-associated protein essential for syn- requires UNC-13 in order to facilitate vesicle-mediated
release of neurotransmitter (Figure S3). This providesaptic vesicle-mediated neurotransmitter release in Dro-
sophila, mammals, and C. elegans [4, 5, 25]. In C. ele- further insight into the receptor-mediated modulation of
transmission via nerve-terminal signaling cascades. Ingans, UNC-13 is regulated by DAG via a pathway
involving cholinergic and serotonergic control of motor addition, the possibility to direct small molecular weight
compounds at latrophilin might provide potential thera-neurons [26, 31]. Furthermore, it has been shown that
a mouse double knockout for (m)UNC-13-1 and (m)UNC- peutic routes to target this pathway in the treatment of
disease.13-2 is resistant to LTX [32]. To determine whether UNC-
13 may be required for the action of emodepside, we Details of Experimental Procedures are provided in
the Supplemental Data.looked at two reduction-of-function alleles, unc-
13(e1091) and the more severe unc-13(s69) [33]. Both
Supplemental Datawere emodepside resistant. Notably, unc-13(s69) was
Supplemental Data including Experimental Procedures and four ad-the only mutant that continued to pump strongly in the
ditional figures are available at http://www.current-biology.com/cgi/
presence of 100 nM and 1 M emodepside (Table 1; content/full/14/15/1374/DC1/.
Figures 4D and S4) and is approximately five times more
resistant than the lat-1 knockout. This indicates that Acknowledgments
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